Holding(s) in Company
Harwood Capital LLP has increased its voting rights in Optima Health PLC to 10.0989%, holding 10,985,000 shares, up from a previous holding of 9.1702%. This acquisition of voting rights occurred on July 17, 2026, and was notified to the issuer on July 20, 2026. The ultimate controlling person for these holdings is Christopher Harwood Bernard Mills, with Oryx International Growth Fund Limited holding the largest portion at 9.1933%.
Select text to share a quote on X · sign in to keep highlights & notes in your OPT notes
Issuer Details
ISIN
GB00BRSCY602
Issuer Name
OPTIMA HEALTH PLC
UK or Non-UK Issuer
UK
Reason for Notification
An acquisition or disposal of voting rights
Details of person subject to the notification obligation
Name
Harwood Capital LLP
City of registered office (if applicable)
Country of registered office (if applicable)
| Name | City of registered office | Country of registered office |
| Harwood Capital Management (Gibraltar) Limited | Gibraltar | Gibraltar |
| Harwood Capital LLP | London | United Kingdom |
| 4. Details of the shareholder | ||
| Name | City of registered office | Country of registered office |
| Harwood Capital LLP | London | United Kingdom |
| North Atlantic Smaller Companies Investment Trust Plc | London | United Kingdom |
| Oryx International Growth Fund Limited | Guernsey | Guernsey |
Date on which the threshold was crossed or reached
17-Jul-2026
Date on which Issuer notified
20-Jul-2026
- Total positions of person(s) subject to the notification obligation
| Resulting situation on the date on which threshold was crossed or reached | 10.098900 | 0.000000 | 10.098900 | 10985000 |
| Position of previous notification (if applicable) | 9.170200 | 0.000000 | 9.170200 | |
| 8A. Voting rights attached to shares | ||||
| Class/Type of shares ISIN code(if possible) | Number of direct voting rights (DTR5.1) | Number of indirect voting rights (DTR5.2.1) | % of direct voting rights (DTR5.1) | % of indirect voting rights (DTR5.2.1) |
| GB00BRSCY602 | 510000 | 0.468900 | ||
| GB00BRSCY602 | 475000 | 0.436700 | ||
| GB00BRSCY602 | 10000000 | 9.193300 | ||
| Sub Total 8.A | 10985000 | 10.098900% | ||
Financial Instruments according to (DTR5.3.1R.(1) (a))
Sub Total 8.B1
- Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
Sub Total 8.B2
- Information in relation to the person subject to the notification obligation
| Christopher Harwood Bernard Mills | Harwood Capital LLP | 0.468900 | 0.000000 | 0.468900% |
| Christopher Harwood Bernard Mills | North Atlantic Smaller Companies Investment Trust Plc | 0.436700 | 0.000000 | 0.436700% |
| Christopher Harwood Bernard Mills | Oryx International Growth Fund Limited | 9.193300 | 9.193300% |
In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
If date does not apply, explain below
- Additional Information
- Date of Completion
20/07/2026
Place Of Completion
London Stock Exchange
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.